Literature DB >> 35498117

Ultrasound assisted synthesis of hybrid quinoline-imidazole derivatives: a green synthetic approach.

Dumitrela Diaconu1, Dorina Amăriucăi-Mantu2, Violeta Mangalagiu1,3, Vasilichia Antoci2, Gheorghita Zbancioc2, Ionel I Mangalagiu2,1.   

Abstract

A green, straightforward and efficient study for obtaining hybrid quinoline-imidazole derivatives under ultrasound (US) irradiation as well as under conventional thermal heating (TH) has been presented. The reaction pathway involves only two steps: the N-alkylation of imidazole ring and a Huisgen [3 + 2] dipolar cycloaddition reaction of ylides to dimethyl acetylenedicarboxylate (DMAD). For both types of reactions, a green workup procedure under US irradiation has been presented. Under US irradiation, the N-alkylation of nitrogen atoms from the imidazole nucleus has outstanding benefits in terms of reaction time, energy consumption and yields, and can thereby be considered an environmentally friendly method. Forty new hybrid quinoline-imidazole compounds have been synthesized: 18 salts, 8 dihydro-benzopyrrolo imidazolo quinoline, 9 benzopyrrolo-imidazolo quinoline and 5 dihydro-pyrroloquinoxaline quinoline cycloadducts. This journal is © The Royal Society of Chemistry.

Entities:  

Year:  2021        PMID: 35498117      PMCID: PMC9044051          DOI: 10.1039/d1ra07484a

Source DB:  PubMed          Journal:  RSC Adv        ISSN: 2046-2069            Impact factor:   3.361


Introduction

Over the past decades, ultrasound (US) assisted reactions have become a modern and successful tool in organic and medicinal chemistry. Compared with conventional thermal heating (TH), the use of US in chemical reactions has some crucial advantages, such as higher yields, better product purity, the possibility to obtain better selectivity and higher reactivity, and reduced reaction times.[1-11,31-33,36] In addition, due to milder reaction conditions, less or suppressed side reactions, energy saving nature, and the use of small amounts of solvents, the reactions become eco-friendly.[6,9-11,27,28] Quinoline and imidazole derivatives are structural scaffolds of huge importance from pharmacological, industrial, and synthetic points of view. As for the pharmacological point of view, they are core scaffolds in medicinal chemistry, having a diverse variety of biological activities such as antiplasmodial and antimalarial, antitubercular, antibacterial, antifungal, anti-HIV, anticancer, anti-inflammatory, antidepressant, analgesic, anti-Alzheimer's, and antihypertensive activities.[12-25] The synthesis of quinoline and imidazole derivatives still remains a challenge for the scientific community because conventional synthesis is often inefficient, with low to moderate yields, the formation of by-products, and expensive and harsh reaction conditions (high temperature, long reaction time, large amount of solvents, catalysts, etc.).[26] In view of our continued preoccupation with the field of US assisted reactions[27-32] and new biological entities with quinoline and imidazole skeletons,[16-18,33,34] we decided to perform a thorough study concerning the synthesis of new entities with hybrid quinoline-imidazole cores, both under US irradiation and conventional TH. In addition, we were also interested in developing an environmentally friendly method for the preparation of these hybrids using US technologies. Equally, we were also interested in the anticancer and antimicrobial potential of these compounds.

Results

In order to achieve our goal, we decided to use our expertise in cycloimmonium ylides chemistry,[35-41] with the Huisgen [3 + 2] dipolar cycloaddition reactions of ylides to dipolarophiles with triple bonds (activated alkynes) being our choice. In this regard, we first obtained the corresponding hybrid quinoline imidazolium salts 3a-i and 3′a-ivia N-alkylation with ω-halogeno-acetophenones 2a-i of the acidic nitrogen from benzimidazole 1 and imidazole 1′ (Scheme 1).
Scheme 1

Synthesis of hybrid quinoline imidazolium salts 3a-i and 3′a-i.

As we may notice from Table 1, the N-alkylation reactions of the imidazole ring under conventional TH requires long reaction times and the yields are moderate to good (around 50–90%). This is why we decided to modify the workup procedure using US irradiation (ultrasound assisted reactions were carried out using a Sonics VCX-130 reactor with titanium horn, operating in pulse mode, having a nominal power of 130 W and a frequency of 20 kHz). The data from Table 1 reveal that the use of US irradiation in the N-alkylation reactions of the imidazole ring have the advantages of remarkable acceleration of the reaction, substantial decrease of reaction time (from 48–96 hours to 1–2 hours) decrease of consumed energy, and slight increase of yields (by about 5–10%). As a result, this workup procedure could be considered as environmentally friendly.

Obtaining quinoline imidazolium salts 3a-i and 3′a-i using conventional TH and US irradiation

Compound3a3b3c3d3e3f3g3h3i
R.t. (h)CV484848484896484848
US1.61.31.51.611.21.51.21.3
Compound3′a3′b3′c3′d3′e3′f3′g3′h3′i
R.t. (h)CV484848484896964848
US1.61.321.61.62.32.31.61.3
Compound3a3b3c3d3e3f3g3h3i
Yield, %CV907556878263748088
US968063918565798490
Compound3′′a3′b3′c3′d3′e3′f3′g3′h3′′i
Yield, %CV568478868151677583
US788682908358708487
As in related cases,[27] the efficiency of US irradiation in the N-alkylation reactions could be explained by the cavitation phenomena leading to enhanced mass transfer and better homogenization of the reaction mixture. In the second step, benzimidazolium ylides 4a-i and imidazolium ylides 4′a-i (generated in situ from the corresponding imidazolium salts 3a-i and 3′a-i, using triethylamine (Et3N) or 1,2-epoxybutane) were treated with dimethyl acetylenedicarboxylate (DMAD), a symmetrically activated alkyne, and a typical Huisgen [3 + 2] cycloaddition took place (Scheme 3).
Scheme 3

The Huisgen 3 + 2 cycloaddition of ylides 4a-i and 4′a-i with DMAD.

In the case of the imidazolium ylides 4′a-i, no matter the conditions we employed for the cycloaddition (US irradiation or conventional TH, with or without catalyst, solvents, etc.), the reactions did not result in any compound, and only decomposition products were obtained (probably because of the instability of the imidazole ring, as we found in a related situation[40]). In the case of the benzimidazolium ylides 4a-i, the cycloaddition reactions took place with the formation of the cycloadducts 6a-i and/or 5a-i and/or 7a-i, according to the conditions we employed (Scheme 3 and Tables 2–4). Thus, when the Huisgen [3 + 2] cycloaddition took place using triethylamine as a catalyst, the reactions occurred differently according to the energy source (Table 2). When conventional TH was used, the reactions did not take place, and again only decomposition products were obtained. When US irradiation was used, the reactions took place within a very short period of time (2–4 minutes) with formation of a mixture of the cycloadducts 6a-i and/or 5a-i and/or 7a-i (Table 2).

Comparative study of US versus CV (conventional) irradiation, using Et3N, for the cycloaddition reactions of ylides 4a-i with DMAD

Compound5a5b5c5d5e5f5g5h5i
Yield, %CV000000000
US00020000014
Compound6a6b6c6d6e6f6g6h6i
Yield, %CV000000000
US669054320
Compound7a7b7c7d7e7f7g7h7i
Yield, %CV000000000
US17340121327000
Initially, the dihydro-benzopyrrolo-imidazolo quinoline derivatives 5a-i are formed via the Huisgen [3 + 2] cycloaddition of ylides 4a-i (canonical structure B) to DMAD. As in related cases,[41-45] the initial cycloaddition is followed by an oxidative dehydrogenation of the dihydro-structure 5, leading to more thermodynamically stable compounds: the aromatized benzopyrrolo-imidazolo quinoline compounds 6a-i. The formation of the dihydro-pyrroloquinoxaline quinoline compounds 7a-i could be explained via the following reaction mechanism (Scheme 2): after the initial Huisgen [3 + 2] cycloadditions which lead to the type I dihydro-benzopyrrolo-imidazolo derivatives, a ring opening of the imidazole cycle occurs simultaneously with a prototropic rearrangement, with the formation of a type II pyrroloaniline derivative. In the next step, rotations of the pyrrole ring around the carbon-nitrogen single bond lead to a favorable conformation of the molecule (type III) which allows cyclization to a quinoxaline cycle (via a nucleophilic attack of the amine electrons to the carbonyl group) with the formation of the dihydro-pyrrolo-quinoxaline quinoline compounds 7a-i. Analogous explications have been furnished by some other authors in related cases.[41-45]
Scheme 2

Reaction mechanism for obtaining dihydro-pyrrolo-quinoxaline quinoline compounds 7a-i.

The formation of cycloadducts 5-7 could be explained via the substituent effect: the electron-repulsive groups favour the formation of the pyrrolo-imidazolo structure of type 5-6, while the electron-withdrawing groups favour the formation of the pyrrolo-quinoxaline structure of type 7. In view of the above considerations, especially the lack of selectivity and low yields of reactions but also the toxicity of the solvent used (chloroform), we decided to modify the workup protocols by changing the solvents and using catalysts. Our next choice was to use 1,2-epoxybutane as a nontoxic solvent and as a scavenger for hydrobromic acid for the synthesis of the dihydro-benzopyrrolo-imidazolo quinoline compounds 5a-i and the benzopyrrolo-imidazolo quinoline compounds 6a-i (Table 3).

Comparative study of US versus CV (conventional) irradiation, using 1,2-epoxybutane, for the cycloaddition reactions of ylides 4a-i with DMAD

Compound5a5b5c5d5e5f5g5h5i
Yield, %CV01415152113131218
US02417292519191922
Compound6a6b6c6d6e6f6g6h6i
Yield, %CV32781091014108
US3756361013108
Compound7a7b7c7d7e7f7g7h7i
Yield, %CV000000000
US000000000
Our first observation is that, under these conditions, the reaction became more selective, with only two products being obtained: the dihydro- and fully aromatized cycloadducts 5a-i and 6a-i. No quinoxaline structures of type 7 were observed. We also noticed that under US irradiation, the global yields are slightly higher (by about 5%) and more importantly, a clear preference for obtaining the dihydro-benzopyrrolo-imidazolo quinoline structure is observed (with about 15% more compared with the aromatized one, in term of yield). We wish to also point out that under US irradiation, the reaction time decreases substantially, from 720–960 minutes under conventional TH to 150–180 minutes under US irradiation (roughly fivefold). Since we were still not satisfied by the obtained results, we decided to perform the cycloaddition reactions in 1,2-epoxybutane using tetrakis(pyridine)cobalt(ii) dichromate (TPCD) as the catalyst. The obtained results are listed in Table 4.

Comparative study US versus CV (conventional) irradiation, using 1,2-epoxybutane and TPCD, for the cycloaddition reactions of ylides 4a-i with DMAD

Compound6a6b6c6d6e6f6g6h6i
Yield, %CV422521393531363037
US452932414240443439
From Table 4 we may notice that, in these conditions, the reactions became selective, and only fully aromatized cycloadducts 6a-i were obtained. We may also notice that under US irradiation, the yields are better, being about 5–10% higher compared with conventional TH. We also wish to point out that under US irradiation, the reaction time decreases dramatically (about twenty times), from 300–480 minutes under conventional TH to 16–20 minutes under US irradiation. Consequently, the consumed energy decreases in the same manner. As a result of all these considerations, we claim that the Huisgen [3 + 2] dipolar cycloaddition reactions of ylides 4a-i with DMAD, in 1,2-epoxybutane and TPCD, are an environmentally friendly workup procedure. The structures of the compounds were proven by elemental and spectral analyses (IR, 1H-NMR, 13C{1H}-NMR, 2D-COSY, 2D-HMQC, long range 2D-HMBC) and were in accordance with the proposed structures.

Conclusions

In conclusion, a green, straightforward and efficient study for obtaining hybrid quinoline-imidazole derivatives under US irradiation as well as under conventional TH has been presented. The reaction pathway involves only two steps: the N-alkylation of the imidazole skeleton and a Huisgen [3 + 2] dipolar cycloaddition reaction of the ylides to DMAD. The use of US irradiation in the N-alkylation reactions of the imidazole ring has the advantages of remarkable acceleration of the reaction, substantial decrease of reaction time (from 48–96 hours to 1–2 hours), decrease of consumed energy, and slight increase of yields (no more than 10%). As a consequence, this workup method could be considered environmentally friendly. The Huisgen [3 + 2] dipolar cycloaddition reaction of benzimidazolium ylides to DMAD generates three types of hybrid quinoline-imidazole cycloadducts and according to the source of energy and solvent used, the reactions pathway could be conducted selectively. Thus, if the fully aromatized benzopyrrolo-imidazolo quinoline cycloadducts are to be obtained, the TPCD catalyst and 1,2-epoxybutane, have to be used both under US irradiation and conventional TH. When dihydro-pyrrolo-quinoxaline quinoline compounds are the final goal, the triethylamine catalyst and chloroform as the solvent are compulsory to be used under US irradiation. If the dihydro-benzopyrrolo-imidazolo quinoline derivatives are intended as major products, 1,2-epoxybutane and US irradiation have to be used. Taking into account the above mentioned points, alongside an obvious decrease in reaction time and energy consumption, and the fact that in the cycloaddition reactions we have used a nontoxic solvent (1,2-epoxybutane), the 1,3 dipolar cycloaddition reactions under US irradiation can be considered an environmentally friendly workup procedure. Forty new hybrid quinoline-imidazole compounds belonging to four different classes have been synthesized: 18 salts, as well as 8 dihydro-benzopyrrolo-imidazolo quinoline, 9 benzopyrrolo-imidazolo quinoline and 5 dihydro-pyrroloquinoxaline quinoline cycloadducts.

Author contributions

The manuscript was written with contributions from all authors.

Conflicts of interest

There are no conflicts to declare.
  30 in total

1.  Synthesis and antituberculosis activity of some new pyridazine derivatives. Part II.

Authors:  Dorina Mantu; Mihaela Cătălina Luca; Costel Moldoveanu; Gheorghita Zbancioc; Ionel I Mangalagiu
Journal:  Eur J Med Chem       Date:  2010-08-18       Impact factor: 6.514

Review 2.  The combined use of microwaves and ultrasound: improved tools in process chemistry and organic synthesis.

Authors:  Giancarlo Cravotto; Pedro Cintas
Journal:  Chemistry       Date:  2007       Impact factor: 5.236

3.  The discovery and optimization of benzimidazoles as selective NaV1.8 blockers for the treatment of pain.

Authors:  Alan D Brown; Sharan K Bagal; Paul Blackwell; David C Blakemore; Bruce Brown; Peter J Bungay; Martin Corless; James Crawforth; David Fengas; David R Fenwick; Victoria Gray; Mark Kemp; Wolfgang Klute; Laia Malet Sanz; Duncan Miller; Yoshihisa Murata; C Elizabeth Payne; Sarah Skerratt; Edward B Stevens; Joseph S Warmus
Journal:  Bioorg Med Chem       Date:  2018-12-04       Impact factor: 3.641

4.  Synthesis and evaluation of tetrahydroisoquinoline-benzimidazole hybrids as multifunctional agents for the treatment of Alzheimer's disease.

Authors:  Yuying Fang; Huihao Zhou; Qiong Gu; Jun Xu
Journal:  Eur J Med Chem       Date:  2019-02-04       Impact factor: 6.514

Review 5.  Dual or multi-targeting inhibitors: The next generation anticancer agents.

Authors:  Nulgumnalli Manjunathaiah Raghavendra; Divya Pingili; Sundeep Kadasi; Akhila Mettu; S V U M Prasad
Journal:  Eur J Med Chem       Date:  2017-10-10       Impact factor: 6.514

6.  Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease.

Authors:  Yi-Xiang Xu; Huan Wang; Xiao-Kang Li; Sheng-Nan Dong; Wen-Wen Liu; Qi Gong; Tian-Duan-Yi Wang; Yun Tang; Jin Zhu; Jian Li; Hai-Yan Zhang; Fei Mao
Journal:  Eur J Med Chem       Date:  2017-08-10       Impact factor: 6.514

7.  Considerations concerning design and mechanism of action of a new class of anticancer dual DNA intercalators.

Authors:  Mihaela Cătălina C Luca; Vasile V Tura; Ionel I Mangalagiu
Journal:  Med Hypotheses       Date:  2010-12       Impact factor: 1.538

Review 8.  Recent advances of imidazole-containing derivatives as anti-tubercular agents.

Authors:  Yi-Lei Fan; Xiao-Hong Jin; Zhong-Ping Huang; Hai-Feng Yu; Zhi-Gang Zeng; Tao Gao; Lian-Shun Feng
Journal:  Eur J Med Chem       Date:  2018-03-07       Impact factor: 6.514

9.  New highlights of the syntheses of pyrrolo[1,2-a]quinoxalin-4-ones.

Authors:  Emilian Georgescu; Alina Nicolescu; Florentina Georgescu; Florina Teodorescu; Daniela Marinescu; Ana-Maria Macsim; Calin Deleanu
Journal:  Beilstein J Org Chem       Date:  2014-10-14       Impact factor: 2.883

10.  The Cycloaddition of the Benzimidazolium Ylides with Alkynes: New Mechanistic Insights.

Authors:  Costel Moldoveanu; Gheorghita Zbancioc; Dorina Mantu; Dan Maftei; Ionel Mangalagiu
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

View more
  1 in total

1.  Quinoline-imidazole/benzimidazole derivatives as dual-/multi-targeting hybrids inhibitors with anticancer and antimicrobial activity.

Authors:  Dumitrela Diaconu; Vasilichia Antoci; Violeta Mangalagiu; Dorina Amariucai-Mantu; Ionel I Mangalagiu
Journal:  Sci Rep       Date:  2022-10-10       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.